CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells
This study reports the CD44 receptor-targeted gold-doxorubicin nanocomposite (<i><sub>T</sub></i>GNC-DOX) for pulsatile chemo-photothermal therapy of triple-negative breast cancer (TNBC). The developed <i><sub>T</sub></i>GNC-DOX was nanometric, having...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |